Given that nucleoside analogs are integral to all modern AML therapy and since gemcitabine, a nucleoside analog that is currently used to treat advanced solid tumors in children15,16demonstrated very potent activity across subtypes in the secondary HTS (<65 nM); and taken these results were val...